These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4346144

  • 1. Effects of angiotensin I and antiotensin II on canine hepatic vascular resistance.
    Di Salvo J, Britton S, Galvas P, Sanders TW.
    Circ Res; 1973 Jan; 32(1):85-92. PubMed ID: 4346144
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for the renal conversion of angiotensin I in the dog.
    Franklin WG, Peach MJ, Gilmore JP.
    Circ Res; 1970 Sep; 27(3):321-4. PubMed ID: 4318121
    [No Abstract] [Full Text] [Related]

  • 3. Central vasomotor stimulation by angiotensin.
    Ferrario CM, Dickinson CJ, McCubbin JW.
    Clin Sci; 1970 Aug; 39(2):239-45. PubMed ID: 4319700
    [No Abstract] [Full Text] [Related]

  • 4. Influence of angiotensin I, angiontensin II and cocaine on adrenergic vasoconstrictor responses in the dog hindpaw.
    Kadowitz PJ, Sweet CS, Brody MJ.
    J Pharmacol Exp Ther; 1972 Nov; 183(2):275-83. PubMed ID: 4343414
    [No Abstract] [Full Text] [Related]

  • 5. Selective renal vascular effects of ethacrynic acid.
    McNay JL, Kishimoto T.
    J Pharmacol Exp Ther; 1970 Jul; 174(1):159-68. PubMed ID: 4316534
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cardiovascular response to vertebral artery infusions of angiotensin in the dog.
    Lowe RD, Scroop GC.
    Clin Sci; 1969 Dec; 37(3):593-603. PubMed ID: 4312145
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC, Zimmerman BG.
    Life Sci; 1980 Oct 06; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract] [Full Text] [Related]

  • 12. Intrarenal conversion of angiotensin I to angiotensin II in the dog.
    Di Salvo J, Peterson A, Montefusco C, Menta M.
    Circ Res; 1971 Oct 06; 29(4):398-406. PubMed ID: 4329373
    [No Abstract] [Full Text] [Related]

  • 13. Neurogenic hypertension, with special reference to the central neurogenic effects of angiotensin.
    Dickinson CJ.
    Circ Res; 1970 Oct 06; 27():Suppl 2:169+. PubMed ID: 4319093
    [No Abstract] [Full Text] [Related]

  • 14. Effects of vasoactive drugs on renal vascular resistance in obstructive disease.
    Shenasky JH, Gillenwater JY, Graham SD, Wooster LD.
    J Urol; 1971 Sep 06; 106(3):355-9. PubMed ID: 4328969
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Localisation of hepatic vascular resistance sites in the isolated dual-perfused rat liver.
    Yang W, Benjamin IS, Alexander B.
    Eur J Pharmacol; 1999 Jan 01; 364(1):13-21. PubMed ID: 9920180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds.
    Withrington PG.
    Br J Pharmacol; 1992 Oct 01; 107(2):296-302. PubMed ID: 1384909
    [Abstract] [Full Text] [Related]

  • 19. Vasopressin and angiotensin on resistance vessels of spleen, intestine, and liver.
    Cohen MM, Sitar DS, McNeill JR, Greenway CV.
    Am J Physiol; 1970 Jun 01; 218(6):1704-6. PubMed ID: 4317202
    [No Abstract] [Full Text] [Related]

  • 20. A central vasomotor action of angiotensin in man.
    Scroop GC, Whelan RF.
    Clin Sci; 1966 Feb 01; 30(1):79-90. PubMed ID: 4286414
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.